Ismigen sublingual tablets 50 mg 30 pcs.

Ismigen is an immunostimulant based on bacterial lysate, which increases the body’s resistance to infections by increasing the number of plasma and secretory antibodies, activating cellular and humoral factors of nonspecific immunity. This leads to a decrease in the frequency of development and severity of respiratory infections, eliminating the need for antibiotics. Ismigen has a dual mechanism of action:

• activates nonspecific resistance (rapid protection within 2-4 weeks from the start of Ismigen) due to membrane antigens that are part of the drug, by activating dendritic cells, neutrophils, macrophages and NK cells; induction of phagocytosis and cell lysis by stimulating adhesion of macrophages to bacteria;
• activates specific immunity (long-term protection for several years) by increasing the level of interleukin-2 production, specific serum IgA, IgG, IgM and secretory IgA, activation of effector CD4 and CD8 T-lymphocytes, activation of B-lymphocytes.

Ismigen is well absorbed in the oral mucosa.

For oral use in adults and children aged 2 years and over.

Treatment of acute processes: dissolve 1 tablet under the tongue for 1-2 minutes once a day (you should refrain from eating for at least 30 minutes). Take daily for at least 10 days until symptoms disappear. The course of treatment involves taking 10 tablets.

Preventive treatment: dissolve 1 tablet under the tongue for 1-2 minutes once a day continuously for 10 days. After a 20-day break, repeat the 10-day course of taking the drug for the next month. The full course of treatment, in which the maximum immunotherapeutic effect is achieved, is 3 months. During the full course of treatment, it is necessary to take 30 Ismigen tablets. In other words, Ismigen is taken in three ten-day courses for 3 months with two 20-day breaks between them. Young children are recommended to first crush the tablet, moisten it with water at room temperature and put the resulting pasty mixture in the oral cavity.

Hypersensitivity to the components of the drug.

Usually well tolerated. Rarely, allergic skin reactions (itching, irritation) may occur.

Use during pregnancy and lactation: Although toxic effects of ismigen in animals have not been observed, it is recommended to avoid use of the drug during the first 3 months of confirmed or predicted pregnancy.

The drug does not affect the ability to drive vehicles and other mechanisms.

In a dry, dark place out of reach of children at a temperature not exceeding 25 °C.

UA / OTH / 0075 / 15.11.06